| Dr Michael Libby Mulhern, MD, PHD | |
|
1112 W 6th St, Ste 214, Lawrence, KS 66044-2215 | |
| (785) 841-2280 | |
| (785) 841-2765 |
| Full Name | Dr Michael Libby Mulhern |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 14 Years |
| Location | 1112 W 6th St, Lawrence, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588975130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 57512-20 (Wisconsin) | Secondary |
| 207W00000X | Ophthalmology | 04-37390 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence Memorial Hospital | Lawrence, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lawrence Eye Care Associates, P.a. | 0941282859 | 2 |
News Archive
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease and sleep apnea, announced today it has secured $23 million in Series C financing.
Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.
Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine.
› Verified 3 days ago
| Entity Name | Lawrence Eye Care Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588619779 PECOS PAC ID: 0941282859 Enrollment ID: O20040603001413 |
News Archive
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease and sleep apnea, announced today it has secured $23 million in Series C financing.
Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.
Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Libby Mulhern, MD, PHD 1112 W 6th St, Ste 214, Lawrence, KS 66044-2215 Ph: (785) 841-2280 | Dr Michael Libby Mulhern, MD, PHD 1112 W 6th St, Ste 214, Lawrence, KS 66044-2215 Ph: (785) 841-2280 |
News Archive
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC).
Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease and sleep apnea, announced today it has secured $23 million in Series C financing.
Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.
Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine.
› Verified 3 days ago
Richard Allen Orchard, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1112 W 6th St, Suite 214, Lawrence, KS 66044 Phone: 785-841-2280 Fax: 785-841-2765 | |
Dr. M Scott Hickman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1429 Oread West St Ste 110a, Lawrence, KS 66049 Phone: 785-424-8805 | |
Lynn Wesley O'neal, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1112 W 6th St, Suite 214, Lawrence, KS 66044 Phone: 785-841-2280 Fax: 785-841-2765 | |
Natalie Marie Koederitz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 346 Maine St Ste 400, Lawrence, KS 66044 Phone: 785-856-7732 Fax: 785-260-6275 | |
Mary Patricia Lange, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1112 W 6th St, Suite 214, Lawrence, KS 66044 Phone: 785-841-2280 Fax: 785-841-2765 |